Randomized phase II trial of Carboplatin plus weekly nab-Paclitaxel versus Cisplatin plus Gemcitabine in patients with chemo-naive stage IIIB/IV or postoperative recurrent squamous cell lung cancer
Latest Information Update: 14 Oct 2019
At a glance
- Drugs Carboplatin (Primary) ; Paclitaxel (Primary) ; Cisplatin; Gemcitabine
- Indications Adenosquamous carcinoma; Lung cancer; Squamous cell cancer
- Focus Therapeutic Use
- 10 Sep 2019 Results presented at the 20th World Conference on Lung Cancer
- 01 May 2013 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan.
- 25 Apr 2013 New trial record